Q32 Bio Inc.(QTTB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

QTTB Q32 Bio Inc.

Pre-Mkt 09-04 08:33:02 EDT

12.80

-0.79

-5.81%

盘前12.92

+0.12+0.94%

08:12 EDT

High13.59	Low12.74	Vol491.58K
Open13.52	D1 Closing13.59	Amplitude6.25%
Mkt Cap380.27M	Tradable Cap267.50M	Total Shares29.71M
T/O6.39M	T/O Rate2.35%	Tradable Shares20.90M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"QTTB","market":"US","secType":"STK","nameCN":"Q32 Bio Inc.","latestPrice":12.8,"timestamp":1788465600000,"preClose":13.59,"halted":0,"volume":491580,"hourTrading":{"tag":"盘前","latestPrice":12.92,"preClose":12.8,"latestTime":"08:12 EDT","volume":307,"amount":3961.299899,"timestamp":1788523941502,"change":0.12,"changeRate":0.009375,"amplitude":0.001562},"delay":0,"changeRate":-0.058130978660779924,"floatShares":20898500,"shares":29708800,"eps":3.0012,"marketStatus":"Pre-Mkt","change":-0.79,"latestTime":"09-04 08:33:02 EDT","open":13.52,"high":13.59,"low":12.74,"amount":6389175.8655,"amplitude":0.062546,"askPrice":13.47,"askSize":5,"bidPrice":11.99,"bidSize":10,"shortable":3,"etf":0,"ttmEps":3.0012,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788528600000},"marketStatusCode":1,"adr":0,"listingDate":1522209600000,"exchange":"NASDAQ","adjPreClose":12.8,"preHourTrading":{"tag":"盘前","latestPrice":12.92,"preClose":12.8,"latestTime":"08:12 EDT","volume":307,"amount":3961.299899,"timestamp":1788523941502,"change":0.12,"changeRate":0.009375,"amplitude":0.001562},"postHourTrading":{"tag":"盘后","latestPrice":13.06,"preClose":12.8,"latestTime":"19:36 EDT","volume":2729,"amount":34985.3885,"timestamp":1788478590484,"change":0.26,"changeRate":0.020313,"amplitude":0.020312},"volumeRatio":1.4686691096327826,"impliedVol":0.8644,"impliedVolPercentile":0.0392},"requestUrl":"/m/hq/s/QTTB/tweets","defaultTab":"tweets","newsList":[{"id":"2664498853","title":"Q32 Bio to Present at Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664498853","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664498853?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:59","pubTimestamp":1788260359,"startTime":"0","endTime":"0","summary":"Q32 Bio to Present at Wells Fargo Healthcare ConferenceQ32 Bio management will attend investor conferences on Sept. 8, Sept. 9, Sept. 15, 2026.Fireside chats set for 3:45 p.m. ET in Boston, 3:55 p.m. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL4fX22D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661427839","title":"Q32 Bio Initiated at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2661427839","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661427839?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:28","pubTimestamp":1787567280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QTTB/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222536","title":"Q32 Bio initiated with an Overweight at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222536","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661222536?lang=en_us&edition=fundamental","pubTime":"2026-08-24 17:10","pubTimestamp":1787562606,"startTime":"0","endTime":"0","summary":"Morgan Stanley initiated coverage of Q32 Bio (QTTB) with an Overweight rating and $34 price target Q32 is a clinical-stage immunology company devel...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/q32-bio-initiated-with-an-overweight-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/q32-bio-initiated-with-an-overweight-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657687203","title":"Q32 Bio Inc. : Wells Fargo Cuts Target Price to $59 from $66","url":"https://stock-news.laohu8.com/highlight/detail?id=2657687203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657687203?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:44","pubTimestamp":1786013069,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN44317I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657524750","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657524750","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657524750?lang=en_us&edition=fundamental","pubTime":"2026-08-06 02:30","pubTimestamp":1785954614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB) wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-and-q32-bio-qttb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-and-q32-bio-qttb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","QTTB","SGXZ57979304.SGD","SG9999001176.USD","IE00B19Z9P08.USD","IE00BJT1NW94.SGD","LU1815336091.USD","IE00BFTCPJ56.SGD","LU2362541513.USD","XBI","LU0823416689.USD","LU1093756325.SGD","LU0079474960.USD","TBXU","BK4023","HCSG","IE00B2B36J28.USD","LU0289739699.SGD","VRTX","GNMX","LU0417517546.SGD","LU1093756168.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IBB","LU0256863811.USD","SG9999001176.SGD","BIB","VERX","LABU","IDNA","BK4532","LU0061475181.USD","IBBQ","BK4581","LU2362541273.HKD","BK4588","LU2468319806.SGD","LU1585245621.USD","LU0109394709.USD","LU0889565916.HKD","BBH","LU2462157665.USD","LU1069344957.HKD","LU0029874061.USD","LU1430594728.SGD","IE00B19Z9Z06.USD","LU2089984988.USD","LU2417539215.USD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657054437","title":"Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2657054437","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657054437?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:09","pubTimestamp":1785931754,"startTime":"0","endTime":"0","summary":"BRIEF-Q32 Bio Reports Second Quarter 2026 Financial Results And Provides Corporate UpdateAug 5 (Reuters)-Q32 Bio Inc.QTTB.O:Q32 BIO REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATESource text:ID:nPn4s7hczaFurther company coverage:QTTB.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUACC3XNS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657680541","title":"Q32 Bio Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657680541","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657680541?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:51","pubTimestamp":1785930687,"startTime":"0","endTime":"0","summary":"Q32 Bio Inc. reports results for the quarter ended June 30 - Earnings SummaryQ32 Bio Inc.QTTB.OQreported a quarterly adjusted loss of 44 cents per share for the quarter ended June 30, higher than the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N4421MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657549852","title":"Q32 Bio Q2 EPS $(0.44) Beats $(0.54) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657549852","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657549852?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:21","pubTimestamp":1785928861,"startTime":"0","endTime":"0","summary":"Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.54) by 18.52 percent. This is a 43.59 percent increase over losses of $(0.78) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60943804/q32-bio-q2-eps-0-44-beats-0-54-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657907545","title":"Q32 Bio Q2 FY26 Net Loss Narrows to $8.95 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657907545","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657907545?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:59","pubTimestamp":1785927579,"startTime":"0","endTime":"0","summary":"Q32 Bio Q2 FY26 net loss narrows to $8.95 millionQ32 Bio posted a net loss of USD 8.95 million, narrowing from USD 9.49 million a year earlier; loss per share improved to USD 0.44.R&D expense fell 17.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL2wzvmS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656925376","title":"Akebia Initiates Phase 2 Basket Trial of Complement Inhibitor Ebribafusp in Rare Kidney Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2656925376","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656925376?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:02","pubTimestamp":1785758533,"startTime":"0","endTime":"0","summary":"Akebia initiates Phase 2 basket trial of complement inhibitor ebribafusp in rare kidney diseasesAkebia Therapeutics launched a Phase 2 basket trial of ebribafusp for rare complement-mediated kidney di","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL3chdgM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4588","SG9999014039.USD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4139","BCDF","LU2210149790.SGD","BK4585","IE00BN0W2T93.GBP","LU2095319765.USD","IE00BN0W2W23.USD","LU0314104364.USD","BK4112","IE00B64PRP62.GBP","NDAQ","IE00BN0W2V16.EUR","QTTB","LU2210150020.SGD","SG9999014013.SGD","SG9999014021.USD","AKBA","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655369038","title":"Q32 Bio Inc Expected to Post a Loss of 54 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2655369038","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655369038?lang=en_us&edition=fundamental","pubTime":"2026-07-31 21:05","pubTimestamp":1785503104,"startTime":"0","endTime":"0","summary":"Q32 Bio Inc <QTTB.OQ> expected to post a loss of54cents a share - Earnings PreviewQ32 Bio IncQTTB.OQQTTB.Ois expected to  show no change in quarterly revenue when it reports  results on August 4 (esti","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL8N43X1XC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654100872","title":"Q32 Bio price target raised to $36 from $13 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2654100872","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654100872?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:00","pubTimestamp":1785232819,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Q32 Bio (QTTB) to $36 from $13 and keeps a Buy rating on the shares. The firm says the positive w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/q32-bio-price-target-raised-to-36-from-13-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/q32-bio-price-target-raised-to-36-from-13-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652238584","title":"Q32 Bio Registers 6.9 Million Shares for Resale","url":"https://stock-news.laohu8.com/highlight/detail?id=2652238584","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652238584?lang=en_us&edition=fundamental","pubTime":"2026-07-18 04:39","pubTimestamp":1784320741,"startTime":"0","endTime":"0","summary":"Q32 Bio  on Friday filed a prospectus covering the resale of up to nearly 6.9 million shares of common stock by selling stockholders, consisting of over 6.7 million shares of common stock and 150,000 shares issuable upon exercise of pre-funded warrants.The company said it will not receive proceeds from sales by the selling stockholders but may receive nominal proceeds from the exercise of pre-funded warrants for cash.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652568238","title":"Q32 Bio files to sell 6.88M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2652568238","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652568238?lang=en_us&edition=fundamental","pubTime":"2026-07-18 04:20","pubTimestamp":1784319621,"startTime":"0","endTime":"0","summary":"16:15 EDT Q32 Bio (QTTB) files to sell 6.88M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, mark...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/q32-bio-files-to-sell-6-88m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/q32-bio-files-to-sell-6-88m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652738280","title":"Q32 Bio - Selling Stockholders May Offer up to 6.88 Mln Shares of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2652738280","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652738280?lang=en_us&edition=fundamental","pubTime":"2026-07-18 04:15","pubTimestamp":1784319318,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nFWN43J0TD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651688784","title":"U.S. Stocks on the Move-johnson & Johnson, Blackrock, Veradermics","url":"https://stock-news.laohu8.com/highlight/detail?id=2651688784","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651688784?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:01","pubTimestamp":1784116909,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Johnson & Johnson, BlackRock, VeradermicsWorkspace search string for individual stock moves:STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call n","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nL6N43H0ON:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765489.SGD","LU1008478684.HKD","SG9999001176.USD","LU0052756011.USD","LU2106854487.HKD","IXJ","SG9999002232.USD","LU1515016050.SGD","LU0820561909.HKD","IE00BVYPNW00.USD","LU1868837136.USD","JNJ","LU2456880835.USD","LU2148611432.USD","LU0070302665.USD","IE00BVYPNV92.GBP","LU1196500208.SGD","IE00BQXX3C00.GBP","LU2089283258.USD","BK4185","LU2023251221.USD","LU2089984988.USD","BK4526","IE00BLSP4239.USD","LU1923622614.USD","LU2265009873.SGD","BK4588","LU0210536198.USD","LU0821914370.USD","LU2125909593.SGD","LU0648001328.SGD","LU0985320562.USD","LU0106831901.USD","LU2063271972.USD","LU0345770993.USD","IE0001KFT4U8.USD","LU0158827948.USD","BK4533","LU1989764664.SGD","IE00BKVL7J92.USD","IE00B64PRP62.GBP","LU1291159041.SGD","LU0949170772.SGD","LU2756315664.SGD","LU1280957306.USD","IE000SO60NU8.SGD","ISUL","LU0251143458.SGD","LU0477156953.USD","LU1929549753.HKD","LU2750360997.AUD","LU1046421795.USD","LU1048588211.SGD","QTTB","LU1145028129.USD","LU1221951129.SGD","LU0234570918.USD","IE00B4R5TH58.HKD","LU0345770308.USD","BK4147","LU0203345920.USD","LU1668664300.SGD","IE00BBT3K403.USD","LU2471134879.HKD","IE00B19Z8X17.USD","LU0122379950.USD","MEDX","LU0234572021.USD","LU2226246903.HKD","LU0390134368.USD","LU0426412945.USD","LU0432979614.USD","IE000M9KFDE8.USD","IE00BFTCPJ56.SGD","LU1066053197.SGD","IE00BYQQ9H92.USD","BK4504","LU0731783048.USD","FTXH","LU1048596156.SGD","LU0912757837.SGD","BK4559","LU0310800965.SGD","BK4602","IE00BFXG1179.USD","IE00B1BXHZ80.USD","JDOC","BK4607","BK4532","LU0964807845.USD","DRAG","LU0823434583.USD","LU2471134796.USD","LU1868836591.USD","LU1105468828.SGD","LU1551013425.SGD","LU1228905540.USD","09988","BK4554","LU1228905037.USD","LU2592432038.USD","BK4227","LU0433182093.SGD","LU0130517989.USD","LU1261432733.SGD","LU0124676726.USD","LU1688375341.USD","LU0006061336.USD","LU0053666078.USD","BK4585","LU2129689514.USD","LU0943347566.SGD","LU0820561818.USD","LU1051769294.HKD","LU1732800096.USD","LU0426417589.USD","LU0211328371.USD","LU2023250843.SGD","LU1244550577.SGD","LU1868837300.USD","LU2112291526.USD","LU1244550494.USD","LU1366333091.USD","BK4538","LU0456842615.SGD","BK4527","LU1235294995.USD","LU1923623000.USD","IBM","IE00BFXG0V08.USD","BLK","LU1074936037.SGD","LU0731783394.SGD","LU0072462343.USD","LU0321505439.SGD","LU0354030511.USD","LU1804176565.USD","LU0979878070.USD","IHF","IE00B42XCP33.USD","IE0002270589.USD","IE000F7OJYX1.SGD","BK4220","IE00BQXX3D17.EUR","LU1509826696.USD","BK4135","BK4568","LU1059921491.USD","LU1267930490.SGD","LU1670628061.USD","LU0882574055.USD","LU0061475181.USD","IE00B3S45H60.SGD","BK4579","IE00B2B36J28.USD","IE00BZ1G4Q59.USD","LU2264538146.SGD","LU2360107671.USD","IE00B3PB1722.GBP","LU1935042991.SGD","LU0289739699.SGD","LU1989764748.USD","BK4505","BK4082","LU2750360641.GBP","LU1880383366.USD","LU1861217088.USD","LU0640476718.USD","LU2505996681.GBP","LU1974910355.USD","BK4581","LU2129689605.HKD","LU0985489474.SGD","SGXZ57979304.SGD","LU1162221912.USD","BK4566","IE00BQXX3F31.USD","LU0128525689.USD","IE0000B7K699.USD","LU1152091754.HKD","LU1244550221.USD","VHT","LU2896262040.SGD","LU1880398471.USD","LU1861220207.SGD","LU0689472784.USD","LU0880133367.SGD","ISRG","ZBH","LU1043141396.HKD","ALBmain","LU0545562505.USD","LU0553294199.USD","IE00B19Z9505.USD","LU0820562030.AUD","BABX","KBAB","LU0689626769.HKD","RXL","BK4592","LU2129689431.USD","LU2324357040.USD","AEHR","PJP","BK4139","MANE","LU0328353924.USD","LU1989771016.USD","LU0157215616.USD","LU1152091168.USD","LU1868836914.USD","BK4134","LU0889566641.SGD","FHLC","XLV","LU2213496289.HKD","LU0096364046.USD","LU1066051811.HKD","LU2125909247.SGD","LU1023059063.AUD","LU2471134952.CNY","LU1051768304.USD","LU1267930227.SGD","LU0501845795.SGD","LU1221951046.USD","LU1769817096.USD","IE00BJT1NW94.SGD","LU0878866978.SGD","LU0097036916.USD","LU0708994859.HKD","LU1496350502.SGD","BK4502","IE000WAW04H5.SGD","IE00B19Z8W00.USD","LU1242518857.USD","LU0792757196.USD","LU1670627923.USD","LU2505996509.AUD","LU0795875086.SGD","LU1003077747.HKD","LU1732799900.SGD","LU1951200564.SGD","IE00BGHQF631.EUR","LU1481011671.HKD","LU1032955483.USD","BABU","LU1057294990.SGD","IE00BDGV0183.EUR","SG9999013999.USD","FDFF","GEHC","IE0034235303.USD","LU0029864427.USD","LU0211327993.USD","IE00B3QW5Z07.USD","IE00B0JY6N72.USD","LU1769817179.HKD","LU2089284900.SGD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","LU0321505868.SGD","LU0742537680.HKD","LU0661504455.SGD","LU0980610538.SGD","LU1066051498.USD","LU0918141705.HKD","LU1046422090.SGD","LU0067412154.USD","LU2430703178.SGD","BK4122","BK4106","BK4567","BK4551","LU0128525929.USD","LU1506573853.SGD","BK4524","BK4558","IE00BJJMRZ35.SGD","LU2347655156.SGD","BK4614","LU2471134523.USD","LU0545039389.USD","LU0868494617.USD","LU1064131342.USD","BK4598","LU2244417387.USD","LU2355687059.USD","BABW","LU0738911758.USD","LU1119994496.HKD","LU1718418525.SGD","LU1043141123.HKD","IHI","LU1551013342.USD","LU1242518931.SGD","LU1150488135.SGD","LU1894683264.USD","PYPL","LU1880398554.USD","LU1988902786.USD","LU1791807156.HKD","LU0797268264.HKD","LU2133065610.SGD","LU1061106388.HKD","LU0058720904.USD","LU1868836757.USD","SG9999014021.USD","SG9999002224.SGD","LU0918141887.USD","LU1267930573.SGD","LU2417539215.USD","IE00BGHQF748.EUR","BK4587","BK4007","LU0795875169.SGD","BK4548","LU2236285917.USD","LU2433249047.HKD","LU1489326972.SGD","BK4565","BMED","LU1282648689.USD","LU1150488218.USD","BK4543","SG9999001176.SGD","PYPG","LU1894683348.USD","BBYY","LU0047713382.USD","LU0098860793.USD","IE00B7SZLL34.SGD","LU2023250504.SGD","LU1914381329.SGD","ONLN","EKG","IE00BF5LJ272.USD","IE0002141913.USD","LU1674673428.USD","LU0210528500.USD","SKYY","IE00B3T34201.USD","BK4503","LU0310799852.SGD","BK4550","IPAY","SG9999001440.SGD","LU0354030438.USD","TDIV","LU1599440770.SGD","SG9999014013.SGD","LU0651946864.USD","LU0079474960.USD","LU0651947912.USD","LU1674673691.USD","LU1066051225.USD","LU1823568750.SGD","BABO","LU1032466523.USD","LU0238689110.USD","IE00BN8TJ469.HKD","BK4535","LU0070217475.USD","LU0994945656.USD","BABA","LU1585245621.USD","LU0203347892.USD","LU0072913022.USD","LU0114720955.EUR","IE00BFMHRM44.USD","LU1267930813.SGD","SG9999014039.USD","LU2602419157.SGD","PYPY","IHE","LU1121112475.USD","LU1883839398.USD","LGHT","LU0772969993.USD","LU0345769128.USD","LU2430703095.HKD","LU0823416689.USD","IE000MB6IJN5.SGD","LU1366192091.USD","LU1951198990.SGD","LU2023250330.USD","SG9999014005.SGD","IE00B19Z3581.USD","LU1983299246.USD","LU1778281490.HKD","IE00B775SV38.USD","LU0823434740.USD","LU1629891620.HKD","LU0106959298.USD","LU0320765646.SGD","BK4563","LU2403377893.USD","LU0187121727.USD","LU1481011911.USD","IYH","LU1084165304.USD","IE00B5TLWC47.USD","LU0310800379.SGD","LU1430594728.SGD","BK4531","LU0208291251.USD","CLIX","LU0345769631.USD","LU2430703251.USD","LU2487616109.SGD","LU0130102774.USD","LU1201861249.SGD","LU0466842654.USD","BK4612","LU0683600562.USD","GDOC","LU2756315318.SGD","IE0009355771.USD","LU0348814723.USD","LU2468319806.SGD","LU0348816934.USD","LU1917777945.USD","IE00BSNM7G36.USD","HCA","IE000BZT7R73.USD","LU0068578508.USD","LU0787776722.HKD","FINX","BK4575","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651845281","title":"Q32 Bio Rises After $200 Mln Equity Raise for Hair-loss Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2651845281","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651845281?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:38","pubTimestamp":1784111914,"startTime":"0","endTime":"0","summary":"BUZZ-Q32 Bio rises after $200 mln equity raise for hair-loss drug** Shares of Q32 BioQTTB.Oup 1.6% premarket on Weds to $18.75 after $200 mln follow-on priced** Waltham, Massachusetts-based biotech late Tues sold ~11 mln shares, including pre-funded warrants, at $18.25** QTTB shares soared 91% to close at $21.38 on Mon after co said its hair-loss drug, bempikibart,showed hair regrowthin mid-stage study** Shares fell nearly 14% to finish at $18.46 on Tues** Co intends to use net proceeds from offering for working capital, research-related expenses, clinical development and commercialization efforts including for advancement of bempikibart into future clinical trials** It has ~23.7 mln shares outstanding, per the prospectus** Morgan Stanley, Jefferies and Cantor Fitzgerald joint bookrunners for offering** Through Tues, QTTB shares have surged more than fivefold YTD** All 5 brokerages covering the stock are bullish; median PT $38, per LSEG","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nL6N43H0MI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023251221.USD","LU0882574139.USD","LU1732799900.SGD","LU2111349929.HKD","LU1791710400.SGD","LU0390134368.USD","LU2271345857.HKD","LU0267386448.USD","LU1244550577.SGD","LU0314104364.USD","LU1363072403.SGD","IAI","LU0006306889.USD","LU1074936037.SGD","LU2487616109.SGD","LU0106261372.USD","LU1162221912.USD","KBWB","LU0210528500.USD","LU2089284900.SGD","IE00BKVL7J92.USD","LU0320765646.SGD","LU2347655156.SGD","LU2028103732.USD","LU1244550221.USD","QTTB","BK4585","LU2089283258.USD","LU2133065610.SGD","LU1989772840.SGD","LU0234570918.USD","LU1791710582.SGD","LU1732800096.USD","LU1720051108.HKD","LU1244550494.USD","LU2357305700.SGD","LU0158827948.USD","LU0053666078.USD","LU0795875169.SGD","LU0158827781.USD","BK4581","BK4588","BK4139","IE00BZ1G4Q59.USD","LU0971096721.USD","BK4516","LU0912757837.SGD","BK4534","LU0528227936.USD","LU0106831901.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651435697","title":"Q32 Bio Prices Offering Including Pre-funded Warrants at USD 18.2499 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2651435697","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651435697?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:59","pubTimestamp":1784084391,"startTime":"0","endTime":"0","summary":"Q32 Bio prices offering including pre-funded warrants at USD 18.2499 eachQ32 Bio priced a $200 million public offering that includes 4,931,506 pre-funded warrants to buy common stock.Pre-funded warran","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL5rCRGD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651435662","title":"Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2651435662","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651435662?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:59","pubTimestamp":1784084369,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA7KVRJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651435660","title":"Q32 Bio - Prices Public Offering of 6.03 Mln Shares at $18.25 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2651435660","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651435660?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:59","pubTimestamp":1784084369,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA7KVRJF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.q32bio.com","stockEarnings":[{"period":"1week","weight":-0.2074},{"period":"1month","weight":-0.2077},{"period":"3month","weight":-0.0236},{"period":"6month","weight":1.7234},{"period":"1year","weight":6.4854},{"period":"ytd","weight":2.8554}],"compareEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":0.0024},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1499},{"period":"1year","weight":0.2011},{"period":"ytd","weight":0.1338}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction in the United States. Its lead product candidate is ADX-097, a humanized anti-C3d monoclonal antibody fusion protein to restore complement regulation, which has completed Phase I clinical trial for the treatment of renal and other complement-mediated diseases of high unmet need, including lupus nephritis, immunoglobulin A nephropathy, complement component 3 glomerulopathy, and anti-neutrophil cytoplasmic antibody-associated vasculitis. The company is also developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin that is Phase II clinical trial for the treatment of atopic dermatitis and alopecia areata. Q32 Bio Inc. was formerly known as AdMIRx Inc. and changed its name to Q32 Bio Inc. in April 2020. The company was founded in 2017 and is based in Waltham, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.019777},{"month":2,"riseRate":0.5,"avgChangeRate":0.070572},{"month":3,"riseRate":0.25,"avgChangeRate":-0.062438},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.082275},{"month":5,"riseRate":0.555556,"avgChangeRate":0.111875},{"month":6,"riseRate":0.555556,"avgChangeRate":0.01181},{"month":7,"riseRate":0.555556,"avgChangeRate":0.224049},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.026666},{"month":9,"riseRate":0.555556,"avgChangeRate":0.015471},{"month":10,"riseRate":0.25,"avgChangeRate":-0.055418},{"month":11,"riseRate":0.375,"avgChangeRate":-0.113432},{"month":12,"riseRate":0.625,"avgChangeRate":-0.026783}],"exchange":"NASDAQ","name":"Q32 Bio Inc.","nameEN":"Q32 Bio Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Q32 Bio Inc.(QTTB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Q32 Bio Inc.(QTTB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Q32 Bio Inc.,QTTB,Q32 Bio Inc.股票,Q32 Bio Inc.股票老虎,Q32 Bio Inc.股票老虎国际,Q32 Bio Inc.行情,Q32 Bio Inc.股票行情,Q32 Bio Inc.股价,Q32 Bio Inc.股市,Q32 Bio Inc.股票价格,Q32 Bio Inc.股票交易,Q32 Bio Inc.股票购买,Q32 Bio Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Q32 Bio Inc.(QTTB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Q32 Bio Inc.(QTTB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction